Target intelligence / Profile preview

Multiple bacterial surface antigens (Pasteurella multocida, Escherichia coli, Trueperella pyogenes, and Fusobacterium necrophorum)

Molecular classification
Bacterial surface protein, Lipopolysaccharide, Adhesin, Antigen
01

Overview

Multiple bacterial surface antigens on Pasteurella multocida, Escherichia coli, Trueperella pyogenes, and Fusobacterium necrophorum represent a composite target profile for veterinary biologicals. These antigens include outer membrane proteins, lipopolysaccharides, and adhesins that are essential for the virulence and survival of these pathogens in livestock [1, 4]. Pasteurella multocida and Escherichia coli are major causes of respiratory and enteric diseases, while Trueperella pyogenes (formerly Arcanobacterium pyogenes) and Fusobacterium necrophorum are primarily associated with pyogenic infections and liver abscesses [2, 3]. Therapeutic strategies targeting these antigens, such as polyvalent antisera (e.g., Poly-Serum), provide passive immunity by delivering antibodies that facilitate bacterial opsonization and neutralization [5]. This approach is particularly relevant in treating complex, polymicrobial conditions like Bovine Respiratory Disease and liver abscess complexes where multiple pathogens contribute to the pathology. Effective targeting of these surface molecules helps reduce bacterial load and mitigates the severity of clinical disease in affected animals [1, 5].

Other names
Bacterial surface antigensPolyvalent bacterial antigensArcanobacterium pyogenes antigensBRD complex antigensShipping fever antigens
02

Mechanism of action

Passive or active immunization targeting surface antigens to promote opsonization, neutralization of toxins, and complement-mediated lysis of the specified bacterial pathogens [5].

03

Biological functions

Bacterial adhesionPathogenesisImmune responseCell colonization
04

Disease associations

InfectionBovine Respiratory DiseaseLiver abscessMetritisEnteritisFoot rot
05

Safety considerations

AnaphylaxisInjection site reactionSerum sicknessHypersensitivity
06

Interacting drugs

Bovine Antiserum

3 more in the full profile.

07

Biomarkers

Antibody titerSerum IgG levelsClinical sign reduction

Beyond the preview

Go deeper on Multiple bacterial surface antigens (Pasteurella multocida, Escherichia coli, Trueperella pyogenes, and Fusobacterium necrophorum).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple bacterial surface antigens (Pasteurella multocida, Escherichia coli, Trueperella pyogenes, and Fusobacterium necrophorum).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call